Newsletter | January 31, 2025

01.31.25 -- Digital Certificates Of Analysis: A Vision For The Transfer Of Quality Data

FEATURED EDITORIAL

Digital Certificates Of Analysis: A Vision For The Transfer Of Quality Data

The pharma/biotech industry must ramp up adoption of digital certificates of analysis, which are transforming the way quality data is transferred between organizations in the supply chain.

2024 Made Us Nervous. Will 2025 Be A Happier New Year?

Chief Editor Louis Garguilo doesn't recall a time of more collective concern over development and manufacturing outsourcing than exhibited during last year's news of Novo Holdings’ purchase of Catalent, and the sale of certain Catalent facilities to Novo Nordisk. That angst was aggravated by the simultaneous drama known as the BIOSECURE Act. Will we have a calmer 2025?

INDUSTRY INSIGHTS

Particle Investigation: Going One Step Further Than Just The Identification

Explore examples of visible particle identification and the root cause investigation, along with a discussion of the performance of additional troubleshooting using advanced and innovative technologies.

The Future Of Small And Large Molecule Bioanalytics

Learn how spatial bioanalysis can provide answers regarding molecule function and form that can improve the quantity and quality of information obtainable in drug development studies.

Maximizing Drug Formulations For First-In-Human Trials

Discover the importance of drug product formulation and manufacture for FIH trials, and how they can determine if the correct dosage is safely provided and, ultimately, gain regulatory approval.

Increasing Bioavailability With Amorphous Solid Dosage Formulations

Consider the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

A Guide To CRO, CMO, And CDMO Partnerships

By partnering with a reputable CDMO, biotech and pharmaceutical companies can leverage their expertise and resources to expedite the development and manufacturing of life-saving medications.

How To Secure A Sustainable Supply Of Raw Materials

How can pharma companies secure the supply of vital APIs and intermediates and maintain consistent manufacturing costs? These steps minimize supply chain insecurity in a rapidly changing market.

SOLUTIONS

Oral Solid Dose Formulation Troubleshooting Support Services

Partner with us to successfully tackle your solid dosage challenges globally with our holistic, science-driven solutions for common tableting issues like capping, lamination, picking, and sticking.

Taste Masking And Customized Release Technologies For OSD Forms

Watch for an overview of taste-masking solutions that can elevate your oral dosage forms, drive the success of your business, and address the needs of multiple, large patient populations.

Wrap-Around Pharmaceutical Labeler: HERMA 132M HC

The 132M HC sets the standard for performance, precision, and reliability. This wrap-around labeler applies labels to cylindrical products with the utmost accuracy at the highest performance.

Capacity Update October 2024: Fill/Finish

Our injectables CDMO expertise can support your molecule, with a team skilled in complex formulations, over 20 commercial products, a 40+ year regulatory history, and a new isolator filler capacity.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: